130 related articles for article (PubMed ID: 25766343)
1. A case of probable bemiparin-induced HIT type II managed with low-dose fondaparinux.
Koufakis T; Tsapakidis K; Margaritis A; Gabranis I
J Postgrad Med; 2015; 61(2):109. PubMed ID: 25766343
[No Abstract] [Full Text] [Related]
2. Treatment of heparin-induced thrombocytopenia with fondaparinux.
Harenberg J; Jörg I; Fenyvesi T
Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
[TBL] [Abstract][Full Text] [Related]
3. A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux.
Koul AN
J Postgrad Med; 2015; 61(4):267. PubMed ID: 26440400
[No Abstract] [Full Text] [Related]
4. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
[TBL] [Abstract][Full Text] [Related]
5. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
[TBL] [Abstract][Full Text] [Related]
6. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
Rota E; Bazzan M; Fantino G
Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
[No Abstract] [Full Text] [Related]
7. Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature.
Brown P; Jay R; Fox A; Oliver M
Hemodial Int; 2013 Jul; 17(3):444-9. PubMed ID: 23216938
[TBL] [Abstract][Full Text] [Related]
8. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
[TBL] [Abstract][Full Text] [Related]
9. [Erythema after subcutaneous heparin treatment].
Brouns AJ; Jie KS
Ned Tijdschr Geneeskd; 2015; 159():A9304. PubMed ID: 26507065
[TBL] [Abstract][Full Text] [Related]
10. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.
Willenborg KL
Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124
[TBL] [Abstract][Full Text] [Related]
11. Nonheparin anticoagulants for heparin-induced thrombocytopenia.
Kelton JG; Arnold DM; Bates SM
N Engl J Med; 2013 Feb; 368(8):737-44. PubMed ID: 23425166
[No Abstract] [Full Text] [Related]
12. Fondaparinux in heparin-induced thrombocytopenia.
Gevaert A; Smets H; Vercauteren R
Acta Cardiol; 2013 Oct; 68(5):517-20. PubMed ID: 24283115
[TBL] [Abstract][Full Text] [Related]
13. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
[TBL] [Abstract][Full Text] [Related]
14. Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
Pistulli R; Oberle V; Figulla HR; Yilmaz A; Pfeifer R
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):76-8. PubMed ID: 21076279
[TBL] [Abstract][Full Text] [Related]
15. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
Badger NO
J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
[TBL] [Abstract][Full Text] [Related]
16. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.
Tokgoz H; Caliskan U; Demir M
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):769-71. PubMed ID: 22964766
[TBL] [Abstract][Full Text] [Related]
17. Fondaparinux: does it cause HIT? Can it treat HIT?
Warkentin TE
Expert Rev Hematol; 2010 Oct; 3(5):567-81. PubMed ID: 21083474
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
Snodgrass MN; Shields J; Rai H
Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
Blackmer AB; Oertel MD; Valgus JM
Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
[TBL] [Abstract][Full Text] [Related]
20. Disappearance of anti-PF4/heparin antibodies under prolonged fondaparinux administration in a patient with DVT associated with LMWH-induced thrombocytopenia.
D'Angelo A; Valle PD; Fattorini A; Luciano C
Thromb Haemost; 2006 Mar; 95(3):573-5. PubMed ID: 16525590
[No Abstract] [Full Text] [Related]
[Next] [New Search]
